Article Text
PDF
Other content recommended for you
- Cystic fibrosis
- Gene therapy in cystic fibrosis
- Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
- A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
- Recent developments and current status of gene therapy using viral vectors in the United Kingdom
- Science, medicine, and the future: Gene therapy
- Delivery of genes into the CF airway
- Gene therapy: targeting the myocardium
- Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
- Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis